(Q43057997)

English

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

scientific article published on 20 May 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

Nahid Beladi Moghadam

object named as

Nahid Beladi Moghadam

4

0 references

object named as

Ali Jannati

11

0 references

Mohammad Ali Sahraian

object named as

Mohammad Ali Sahraian

6

0 references

Sanaz Ahmadi Karvigh

2

object named as

Sanaz Ahmadi Karvigh

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Mansoureh Togha

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Masoud Nabavi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Mohammad Hossein Harirchian

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Anahita Enzevaei

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Alireza Nourian

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Hossein Ghanaati

9

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Kavous Firouznia

10

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Majid Shekiba

12

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

20 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

848-854

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non responders.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin

1 reference

https://api.crossref.org/works/10.1177%2F1352458510369147

21 January 2018

Identifiers

10.1177/1352458510369147

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43057997&oldid=2119122179"